Share:
Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission ( SEC ), under which it may offer and sell, from time to time, shares of its common stock having an aggregate offering price of up to $75,000,000 million through an at-the-market equity offering program (the ATM Program ). The timing and amount of any sales will be determined by a variety of factors considered by Clovis Oncology.
Shares of Clovis Oncology common stock will be offered through J.P. Morgan Securities LLC ( JPM ) and BofA Securities, Inc. ( BofA Securities ), who are serving as the distribution agents. JPM and BofA Securities may sell the shares of our common stock by any method deemed to be an at-the-market offering defined by Rule 415(a)(4) of the Securities Act of 1933, as amended, including without limitation, sales in ordinary brokers transactions, including directly on the Nasdaq Global Select Market or into a
14 May 2021 | 07:28am
StockMarketWire.com - Private equity fund Apax Global Alpha said Global-e, a provider of cross-border e-commerce solutions, had made its public market debut on the Nasdaq Global Select Market on 12 May 2021.
The closing price per share of common stock on 12 May was $25.5. At the closing Price, and based on closing exchange rates, Apax Global Alpha s look through position in Global-e was valued at about €17.4 million. This represents an uplift of 234% or c.€12.2m to Global-e s fair value at 31 March 20212 and an uplift of c.0.9% of AGA s Adjusted NAV (or €0.02 per share) at 31 March 2021. The IPO was a primary offering of shares and AGA is not expected to receive proceeds, the company said.
Calliditas Therapeutics to host conference call to provide Business Update for the first quarter of 2021
On May 18
th, 2021, Calliditas Therapeutics AB (publ) ( Calliditas ) will publish its financial report for the first quarter of 2021, and at 2.30 pm CET will host a conference call to present and discuss the results.
The event will be hosted by the company s CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, and will be held in English. The presentation will be webcast live and will also be made available online on the Calliditas website after the call.
Webcast link: https://tv.streamfabriken.com/calliditas-therapeutics-q1-2021
Teleconference: SE: +46850558366 UK: + 443333009271 US: + 18335268381
FTSE 100 recovers above 7000 after yesterday s inflation worries | 14 May 2021 stockmarketwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockmarketwire.com Daily Mail and Mail on Sunday newspapers.